Previous Close | 2.2500 |
Open | 2.2200 |
Bid | 0.0000 x 1800 |
Ask | 0.0000 x 900 |
Day's Range | 2.1100 - 2.2400 |
52 Week Range | 2.1100 - 7.2000 |
Volume | |
Avg. Volume | 917,598 |
Market Cap | 168.675M |
Beta (5Y Monthly) | 1.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.7330 |
Earnings Date | Jul 26, 2022 - Aug 01, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 17.56 |
Subscribe to Yahoo Finance Plus to view Fair Value for VKTX
Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation as part of the H.C. Wainwright Global Investment Conference. The conference will take place May 23-25, 2022.
In this piece, we will take a look at the ten stocks to invest in under $20 according to Sio Capital. To skip the bottom five stocks in this list, head on over to 5 Stocks to Invest In Under $20 According to Michael Castor’s Sio Capital. Sio Capital is a hedge fund based out […]
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...